Fintech PR
Cost of living crisis: Burns to children from hot water bottles have increased by 45% reported by Children’s Burns Trust
Brand new insight released today on National Burn Awareness Day 2023 shows an alarming increase in the number of life-altering burn injuries to babies and children involving hot water bottles.
LONDON, Oct. 11, 2023 /PRNewswire/ — New data from the International Burn Injury Database (iBID), shows that burn and scalds to children in the first six months of 2023 increased by 45% compared with the same period in 2022. Burns and scalds to adults and the elderly from hot water bottles have also increased by 19%.
The Children’s Burns Trust and British Burn Association, have released this exclusive insight to raise awareness of the risks posed by hot water bottles and the devastating nature of burns and scalds, which can lead to life-altering injuries.
The ongoing cost of living crisis, and the financial pressures that households have been under for some time – coupled with universal credit deductions – has led to a change in behaviour where parents are looking for ways to keep their children and families warm without increasing their energy bills.
The Children’s Burns Trust, the only UK charity dedicated to supporting burn-injured children and their families, is concerned that the ongoing financial climate and high cost of energy, will see more and more parents using hot water bottles as the winter months begin.
Dad Peter wants to warn of the dangers of using hot water bottles with children after his son, Freddie, sustained a 15% burn to his thighs, abdomen and hands when the hot water bottle he was using split open into his lap. “Freddie was using a hot water bottle on a cold evening to help keep him warm. We heard Freddie scream and turned to see that the hot water bottle had split, spilling all over his lap and legs. We immediately cooled the burn in the bath. The pain was unbearable while we awaited the Ambulance.
A week after the injury we thought he was healing well but then he developed a high temperature and following a dressing change we were told his burn was potentially life threatening. Freddie has since had to undergo 5 operations involving major skin grafts and is still receiving scar management care and support from the specialist burns team. The impact of a burn injury cannot be underestimated and I want parents to know the damage that can be caused by hot water – a burn injury is for life.“
Ken Dunn, Consultant Burns and Plastic Surgeon (retired) and Vice Chair of The Children’s Burns Trust, said:
“The significant increase we have seen of injuries from hot water bottles to children is alarming and as the colder months of the year approach – coupled with the financial strain that many households are under – we’re urging families to avoid using hot water bottles for children.
If you do use them at all in the home, you should remember two key pieces of information about how to use them safely – never fill them with boiling water and always check the rubber flower symbol found on the neck which shows which month and year the hot water bottle was made. Any bottle older than two years old should be replaced.
NOTES TO EDITORS:
Picture – child injured by hot water bottle
Available to interview:
- Peter – Dad of Freddie who was burned by a hot water bottle at 10 years old
- Children’s Burns Trust
– Ken Dunn BSc FRCS(Lond) FRCS(plast) FRCS(ed), Vice Chair of Trustees, Consultant Burns and Plastic Surgeon (retired)
– Chris Bigland, Trustee and Deputy Chief Fire Officer for Bedfordshire Fire and Rescue Service
Hot water bottle safety
Rubber deteriorates over time so old hot water bottles can burst or leak and cause serious burns. Check for signs of wear and tear regularly by looking at the flower symbol which indicates exactly when it was made. Don’t use a hot water bottle that is more than 2 years old.
Never fill a hot water bottle with boiling water.
First Aid
National Burn Awareness Day helps to promote the vital message of the importance of good first aid if a burn or scald does occur: COOL for 20 minutes under cool running water, CALL 999 OR 111 or your GP for advice, COVER the burn loosely with cling film.
All statistics have been provided by the International Burn Injury Database (iBID), incorporating data collected from all NHS Burn Services in England and Wales, they do not include the minor burns and scalds that are treated by Accident and Emergency Departments.
For more information: [email protected], https://cbtrust.org.uk/get-informed/campaigns/national-burn-awareness-day/
X (Twitter): @cbtofficial
Facebook: @childrensburnstrust
Instagram: @childrensburnstrust
TikTok: @childrensburnstrust
Photo – https://mma.prnewswire.com/media/2242266/Childrens_Burns_Trust_Hot_Water_Bottle_Burns.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cost-of-living-crisis-burns-to-children-from-hot-water-bottles-have-increased-by-45-reported-by-childrens-burns-trust-301951158.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News4 days ago
Letter from Gatemore Capital Management LLP to Elementis PLC
-
Latest News5 days ago
Shanghai Electric Releases ESG Report, Highlighting Sustainable Development Achievements in 2023
-
Latest News4 days ago
Hyosung Heavy Industries Ranked on BNEF’s Energy Storage Tier 1 List
-
Latest News4 days ago
Talino, Chemonics invest in startup Higala, the Philippines’ pioneering inclusive instant payment system
-
Latest News4 days ago
Report Finds that Huawei DigiTruck Training Helps Boost Income, Employment and Entrepreneurship
-
Latest News5 days ago
Zilch Partners with Amazon Web Services to Drive AI Innovation
-
Latest News7 days ago
Enigmatic Smile Acquires Fidel API’s Loyalty Business
-
Latest News3 days ago
LeddarTech Reports Annual Shareholder Meeting Results